DK291389D0 - Middel til fjernelse eller inaktivering af uoenskede komponenter i blod eller andre legemsvaesker - Google Patents

Middel til fjernelse eller inaktivering af uoenskede komponenter i blod eller andre legemsvaesker

Info

Publication number
DK291389D0
DK291389D0 DK291389A DK291389A DK291389D0 DK 291389 D0 DK291389 D0 DK 291389D0 DK 291389 A DK291389 A DK 291389A DK 291389 A DK291389 A DK 291389A DK 291389 D0 DK291389 D0 DK 291389D0
Authority
DK
Denmark
Prior art keywords
blood
inactivation
removal
body fluids
unwanted components
Prior art date
Application number
DK291389A
Other languages
English (en)
Other versions
DK169306B1 (da
DK291389A (da
Inventor
Henry Marinus Christensen
Hans Berg Andreasen
Original Assignee
Christensen Henry M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christensen Henry M filed Critical Christensen Henry M
Publication of DK291389D0 publication Critical patent/DK291389D0/da
Priority to DK291389A priority Critical patent/DK169306B1/da
Priority to ZA904546A priority patent/ZA904546B/xx
Priority to NZ234034A priority patent/NZ234034A/xx
Priority to IE213190A priority patent/IE62998B1/en
Priority to IL9471290A priority patent/IL94712A/en
Priority to KR1019910701848A priority patent/KR920702624A/ko
Priority to AT90917756T priority patent/ATE111739T1/de
Priority to MD95-0010A priority patent/MD950010A/ro
Priority to DE69012818T priority patent/DE69012818T2/de
Priority to AU59401/90A priority patent/AU635464B2/en
Priority to JP2509373A priority patent/JPH04506211A/ja
Priority to HU906647A priority patent/HU208083B/hu
Priority to DK90917756.0T priority patent/DK0481013T3/da
Priority to PCT/DK1990/000151 priority patent/WO1990015610A1/en
Priority to EP90917756A priority patent/EP0481013B1/en
Priority to ES90917756T priority patent/ES2062571T3/es
Priority to CA002058442A priority patent/CA2058442A1/en
Publication of DK291389A publication Critical patent/DK291389A/da
Priority to NO91914854A priority patent/NO914854L/no
Priority to BG095622A priority patent/BG60089B2/bg
Priority to FI915888A priority patent/FI95139C/fi
Priority to US07/806,206 priority patent/US5314878A/en
Priority to OA60112A priority patent/OA09646A/en
Priority to US08/205,629 priority patent/US5514668A/en
Application granted granted Critical
Publication of DK169306B1 publication Critical patent/DK169306B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0021—Dextran, i.e. (alpha-1,4)-D-glucan; Derivatives thereof, e.g. Sephadex, i.e. crosslinked dextran
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
    • B01J20/3206—Organic carriers, supports or substrates
    • B01J20/3208—Polymeric carriers, supports or substrates
    • B01J20/3212—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
    • B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3214—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the method for obtaining this coating or impregnating
    • B01J20/3217—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond
    • B01J20/3219—Resulting in a chemical bond between the coating or impregnating layer and the carrier, support or substrate, e.g. a covalent bond involving a particular spacer or linking group, e.g. for attaching an active group
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244—Non-macromolecular compounds
    • B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
    • B01J20/3248—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244—Non-macromolecular compounds
    • B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
    • B01J20/3248—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
    • B01J20/3253—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such comprising a cyclic structure not containing any of the heteroatoms nitrogen, oxygen or sulfur, e.g. aromatic structures
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244—Non-macromolecular compounds
    • B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
    • B01J20/3248—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such
    • B01J20/3255—Non-macromolecular compounds having a well defined chemical structure the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such comprising a cyclic structure containing at least one of the heteroatoms nitrogen, oxygen or sulfur, e.g. heterocyclic or heteroaromatic structures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00—Aspects relating to sorbent materials
    • B01J2220/40—Aspects relating to the composition of sorbent or filter aid materials
    • B01J2220/48—Sorbents characterised by the starting material used for their preparation
    • B01J2220/4812—Sorbents characterised by the starting material used for their preparation the starting material being of organic character
    • B01J2220/4825—Polysaccharides or cellulose materials, e.g. starch, chitin, sawdust, wood, straw, cotton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Detergent Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
DK291389A 1989-06-14 1989-06-14 Middel til fjernelse eller inaktivering af uønskede komponenter i blod eller andre ekstracellulære legemsvæsker samt fremgangsmåde til fremstilling af dextran-O-carbonyl-benzo-18-crown-6 og af dextran-hydroxyethylbenzo-18-crown-6 DK169306B1 (da)

Priority Applications (23)

Application Number Priority Date Filing Date Title
DK291389A DK169306B1 (da) 1989-06-14 1989-06-14 Middel til fjernelse eller inaktivering af uønskede komponenter i blod eller andre ekstracellulære legemsvæsker samt fremgangsmåde til fremstilling af dextran-O-carbonyl-benzo-18-crown-6 og af dextran-hydroxyethylbenzo-18-crown-6
ZA904546A ZA904546B (en) 1989-06-14 1990-06-12 A composition for removing or inactivating harmful components in blood or other extracellular body fluids
NZ234034A NZ234034A (en) 1989-06-14 1990-06-12 Compositions containing a crownether bound to a polysaccharide
IE213190A IE62998B1 (en) 1989-06-14 1990-06-13 Composition for removing or inactivating harmful components in blood or other body fluids
IL9471290A IL94712A (en) 1989-06-14 1990-06-13 Polysaccharide-bound crownethers and compositions containing them for removing or inactivating harmful components in blood or other extracellular body fluids
DK90917756.0T DK0481013T3 (da) 1989-06-14 1990-06-14 Middel til fjernelse eller inaktivering af skadelige komponenter i blod eller andre ekstracellulære legemsvæsker
CA002058442A CA2058442A1 (en) 1989-06-14 1990-06-14 Composition for removing or inactivating harmful components in blood or other extracellular body fluids
MD95-0010A MD950010A (ro) 1989-06-14 1990-06-14 Compoziţie pentru înlăturarea sau dezactivarea componentelor dăunătoare în sînge sau alte lichide extracelulare ale organismului şi procedeu de obţinere
DE69012818T DE69012818T2 (de) 1989-06-14 1990-06-14 Zusammensetzung zur beseitigung und inaktivierung von schadstoffen im blut oder sonstigen extrazellularen körperflüssigkeiten.
AU59401/90A AU635464B2 (en) 1989-06-14 1990-06-14 Composition for removing or inactivating harmful components in blood or other extracellular body fluids
JP2509373A JPH04506211A (ja) 1989-06-14 1990-06-14 血液または他の細胞外体液中の有害成分を除去または不活性化する組成物
HU906647A HU208083B (en) 1989-06-14 1990-06-14 Process for producing composition suitable for inactivating or removing deleterious materials from blood or other extracellular liquid
KR1019910701848A KR920702624A (ko) 1989-06-14 1990-06-14 혈액 또는 기타 세포외 체액중의 유해 성분을 제거하거나 이를 비활성화시키기 위한 조성물
PCT/DK1990/000151 WO1990015610A1 (en) 1989-06-14 1990-06-14 A composition for removing or inactivating harmful components in blood or other extracellular body fluids
EP90917756A EP0481013B1 (en) 1989-06-14 1990-06-14 A composition for removing or inactivating harmful components in blood or other extracellular body fluids
ES90917756T ES2062571T3 (es) 1989-06-14 1990-06-14 Composicion para eliminar o inactivar componentes dañinos en sangre u otros fluidos corporales extracelulares.
AT90917756T ATE111739T1 (de) 1989-06-14 1990-06-14 Zusammensetzung zur beseitigung und inaktivierung von schadstoffen im blut oder sonstigen extrazellularen körperflüssigkeiten.
NO91914854A NO914854L (no) 1989-06-14 1991-12-10 Blanding for aa fjerne eller inaktivere skadelige komponenter i blod eller andre ekstracellulaere kroppsvaesker
BG095622A BG60089B2 (bg) 1989-06-14 1991-12-12 Състав за отстраняване или инактивиране на вредни съставки в кръвта у хора и животни
FI915888A FI95139C (fi) 1989-06-14 1991-12-13 Analogiamenetelmä terapeuttisesti käyttökelpoisen, kruunueetterillä substituoidun polysakkaridin valmistamiseksi
US07/806,206 US5314878A (en) 1989-06-14 1991-12-13 Composition for removing or inactivating harmful components in blood or other extracellular body fluids
OA60112A OA09646A (en) 1989-06-14 1991-12-13 A composition for removing or inactivating harmful components in blood or other extracellular body fluids
US08/205,629 US5514668A (en) 1989-06-14 1994-03-04 Composition for removing or inactivating harmful components in blood or other extracellular body fluids

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK291389 1989-06-14
DK291389A DK169306B1 (da) 1989-06-14 1989-06-14 Middel til fjernelse eller inaktivering af uønskede komponenter i blod eller andre ekstracellulære legemsvæsker samt fremgangsmåde til fremstilling af dextran-O-carbonyl-benzo-18-crown-6 og af dextran-hydroxyethylbenzo-18-crown-6

Publications (3)

Publication Number Publication Date
DK291389D0 true DK291389D0 (da) 1989-06-14
DK291389A DK291389A (da) 1990-12-15
DK169306B1 DK169306B1 (da) 1994-10-10

Family

ID=8117054

Family Applications (2)

Application Number Title Priority Date Filing Date
DK291389A DK169306B1 (da) 1989-06-14 1989-06-14 Middel til fjernelse eller inaktivering af uønskede komponenter i blod eller andre ekstracellulære legemsvæsker samt fremgangsmåde til fremstilling af dextran-O-carbonyl-benzo-18-crown-6 og af dextran-hydroxyethylbenzo-18-crown-6
DK90917756.0T DK0481013T3 (da) 1989-06-14 1990-06-14 Middel til fjernelse eller inaktivering af skadelige komponenter i blod eller andre ekstracellulære legemsvæsker

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK90917756.0T DK0481013T3 (da) 1989-06-14 1990-06-14 Middel til fjernelse eller inaktivering af skadelige komponenter i blod eller andre ekstracellulære legemsvæsker

Country Status (21)

Country Link
US (2) US5314878A (da)
EP (1) EP0481013B1 (da)
JP (1) JPH04506211A (da)
KR (1) KR920702624A (da)
AT (1) ATE111739T1 (da)
AU (1) AU635464B2 (da)
BG (1) BG60089B2 (da)
CA (1) CA2058442A1 (da)
DE (1) DE69012818T2 (da)
DK (2) DK169306B1 (da)
ES (1) ES2062571T3 (da)
FI (1) FI95139C (da)
HU (1) HU208083B (da)
IE (1) IE62998B1 (da)
IL (1) IL94712A (da)
MD (1) MD950010A (da)
NO (1) NO914854L (da)
NZ (1) NZ234034A (da)
OA (1) OA09646A (da)
WO (1) WO1990015610A1 (da)
ZA (1) ZA904546B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU623901B2 (en) * 1988-01-26 1992-05-28 Nycomed As Paramagnetic compounds comprising chelating moiety, linker group macro molecule and paramagnetic metal
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
GB201506663D0 (en) * 2015-04-20 2015-06-03 Komplexis S R L In-vivo delivery of ion chelating ligands for therapy

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113739A (en) * 1974-01-28 1978-09-12 The Dow Chemical Company Process for preparation of (poly)cyclic polyethers
US3965116A (en) * 1974-09-12 1976-06-22 The Regents Of The University Of California Multioxymacrocycles
US3997565A (en) * 1975-09-19 1976-12-14 E. I. Du Pont De Nemours And Company Acylcrownether oximes and oxime ethers
US4024158A (en) * 1975-09-19 1977-05-17 E. I. Du Pont De Nemours And Company Aroylcrownethers
US4474963A (en) * 1980-11-03 1984-10-02 W. R. Grace & Co. Crown ether compositions with sidearms affording enhanced cation binding
US4562272A (en) * 1981-03-27 1985-12-31 Union Carbide Corporation Process for preparing cyclic polyethers
HU187360B (en) * 1981-09-22 1985-12-28 Chinoin Gyogyszer Es Vegyeszet Komplex-forming cyclodextrine-crown-ether derivatives and process for producing them
US4436923A (en) * 1982-06-07 1984-03-13 The President And Trustees Of The Miami University Trifluoromethyl-substituted chromogenic crown ethers and methods of using same
JPS595180A (ja) * 1982-06-30 1984-01-12 Toshiyuki Shono ビスクラウンエ−テル誘導体とその用途
US4631119A (en) * 1983-11-23 1986-12-23 W. R. Grace & Co. Reversible, electrochemically-switched lariat ethers
US4767614A (en) * 1984-02-29 1988-08-30 Wm. Wrigley Jr. Company Modified dextrans in a dental health method deactivating glucosyltransferase enzymes
US4570004A (en) * 1984-04-06 1986-02-11 The Board Of Regents, University Of Texas System Perfluoro crown ethers
US4794000A (en) * 1987-01-08 1988-12-27 Synthetic Blood Corporation Coacervate-based oral delivery system for medically useful compositions
US4777270A (en) * 1985-01-25 1988-10-11 Pfizer Inc. Macrocyclic polyether carboxylic acids
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
IT1214708B (it) * 1986-08-01 1990-01-18 Medosan Ind Biochimi Impiego del dietilaminoetil-destrano (deae-d) come farmaco antidiabetico (diabete tipo i-ii-iii) e regolatore del metabolismo glucidico
GB8702569D0 (en) * 1987-02-05 1987-03-11 Nat Res Dev Moiety for selective separation
EP0285357A3 (en) * 1987-03-31 1989-10-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Control of retroviruses
GB8719042D0 (en) * 1987-08-12 1987-09-16 Parker D Conjugate compounds
US5077198A (en) * 1988-04-14 1991-12-31 Eastman Kodak Company Diagnostic kit and method for rapid detection of antibodies
US5089479A (en) * 1988-11-28 1992-02-18 Krivan Howard C Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide
US5008116A (en) * 1988-11-14 1991-04-16 Frederick Cahn Immunostimulatory microsphere

Also Published As

Publication number Publication date
ATE111739T1 (de) 1994-10-15
FI915888A0 (fi) 1991-12-13
NZ234034A (en) 1991-11-26
WO1990015610A1 (en) 1990-12-27
DK0481013T3 (da) 1995-04-10
JPH04506211A (ja) 1992-10-29
ZA904546B (en) 1991-04-24
HUT59011A (en) 1992-04-28
MD950010A (ro) 1996-05-31
AU5940190A (en) 1991-01-08
NO914854D0 (no) 1991-12-10
BG60089B2 (bg) 1993-10-29
US5314878A (en) 1994-05-24
DE69012818D1 (de) 1994-10-27
FI95139B (fi) 1995-09-15
IE902131A1 (en) 1991-01-02
DK169306B1 (da) 1994-10-10
IE902131L (en) 1990-12-14
OA09646A (en) 1993-04-30
AU635464B2 (en) 1993-03-18
HU906647D0 (en) 1992-02-28
CA2058442A1 (en) 1990-12-15
NO914854L (no) 1991-12-10
EP0481013B1 (en) 1994-09-21
FI95139C (fi) 1995-12-27
IL94712A (en) 1994-11-28
IE62998B1 (en) 1995-03-08
US5514668A (en) 1996-05-07
ES2062571T3 (es) 1994-12-16
DK291389A (da) 1990-12-15
IL94712A0 (en) 1991-04-15
EP0481013A1 (en) 1992-04-22
HU208083B (en) 1993-08-30
KR920702624A (ko) 1992-10-06
DE69012818T2 (de) 1995-03-30

Similar Documents

Publication Publication Date Title
EP0619722A4 (en) PREPARING A BONE FOR A TRANSPLANTATION.
DK30391D0 (da) Middel bestaaende af cavitat- eller clatratdannende vaert/gaest-komplekser som kontrastmiddel
AR001811A1 (es) Anticuerpos anti-icam-1 modificados y su uso en eltratamiento de inflamaciones
DE69733826D1 (de) Behandlung von leukocyten durch photopheresis
FR2660189B1 (fr) Dispositif destine a etre implante dans un vaisseau avec des pattes laterales a dents antagonistes.
SE8205160D0 (sv) Slangset avsett for extracorporeal behandling av blod och liknande omtaliga vetskor
AR006023A1 (es) Vacuna contra el sindrome reproductivo y respiratorio porcino
ATE102502T1 (de) Verbesserungen an membranfiltern fuer ultraoder mikrofiltration von fluessigkeiten, insbesondere von wasser.
SE8205159L (sv) Slangset avsett for extracorporeal behandlin av blod och liknande omtaliga vetskor
DK291389D0 (da) Middel til fjernelse eller inaktivering af uoenskede komponenter i blod eller andre legemsvaesker
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
ES8608884A1 (es) Un procedimiento de eliminacion del virus lav.
EP0400518A3 (en) Auto transfusion system for the collection, treatment and return of a patient's blood
DE3767308D1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
IT1306643B1 (it) Processo per la preparazione dei composti autoreticolati dell'acidoialuronico e dei suoi derivati ottenibili mediante la tecnica
DK0385909T3 (da) Kit eller middel til forebyggelse eller behandling af HIV-1-infektioner
SE8101114L (sv) Forfarande for rening av glukosaminoglukaner
ATE62599T1 (de) Verwendung einer loesung von alpha-chymotrypsin.
KR920006008A (ko) 골(骨) 형성 촉진 물질의 제조법
SE9900277L (sv) Skydd för inneslutning av en extremitet vid undersökning och/ eller behandling
DE59405845D1 (de) Verwendung von 2-Methylamino-2-phenylcyclohexanon zur Behandlung von Infektionen und zur Immunmodulation
Berlie An ultrastructural examination of the myxobacteria Cystobacter fuscus, Melittangium lichenicola and Polyangium cellulosum.
Karandashov et al. Changes in rheological properties of the blood after irradiation with helium-neon laser
UA31350A (uk) Спосіб екстрації сублюксован0го кришталика
UA31309A (uk) Спосіб лікування захворювань системи кровообігу

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed